IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Disorder Related to Transplantation
M.D. Anderson Cancer Centermonoclonal_antibodyPhase 1Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 37/ 100
- Competitive Position
- 95/ 100
Competitive context
14 Active assets in the Disorder Related to Transplantation cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
TACROLIMUS University of Illinois at Chicago | Phase 4 | BBB |
CYCLOSPORIN A Fernanda P Silveira, MD, MS | Phase 4 | BBB |
Rapamycin Wyeth is now a wholly owned subsidiary of Pfizer | Phase 4 | BBB |
Busulphan M.D. Anderson Cancer Center | Phase 3 | BB |
Fludarabine M.D. Anderson Cancer Center | Phase 3 | BB |
View all 33 →
Same molecule, other indications
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →